Publications > Abstracts of FMD-DISCONVAC publications
- Lefebvre, D.J., Neyts, J., De Clercq, K., 2010, Development of a foot-and-mouth disease infection model in severe combined immunodeficient mice for the preliminary evaluation of antiviral drugs., Transboundary and Emerging Diseases, 57(6), 430-433,
- Nagendrakumar SB, Srinivasan VA, Madhanmohan M, Yuvaraj S, Parida S, Di Nardo A, Horsington J, Paton DJ., 2011, Evaluation of cross-protection between O(1) Manisa and O(1) Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O(1) Manisa antigen., Vaccine, epub ahead of print, xx,
- Willems, T., Lefebvre, D.J., Neyts, J., De Clercq, K., 2011, Diagnostic performance and application of two commercially available cell viability assays in foot-and-mouth disease research, Journal of Virological Methods, 173, 108-114,
- M. Carocci, N. Cordonnier, H. Huet, A. Romey, A. Relmy, K. Gorna, S. Blaise-Boisseau, S. Zientara and L. Bakkali Kassimi, 2011, Encephalomyocarditis Virus 2A Protein Is Required for Viral Pathogenesis and Inhibition of Apoptosis, Journal of Virology, Oct. , 85 (20), 10741-10754,
- Richard Reeve, Sarah Cox, Eliana Smitsaart, Claudia Perez Beascoechea, Bernd Haas, Eduardo Maradei, Daniel T. Haydon, Paul Barnett, 2011, Reducing animal experimentation in foot-and-mouth disease vaccine potency tests, Vaccine, Jul 26, 29 (33), 5467-5473,
- Nigel P. Ferri, Santina Grazioli, Geoffrey H. Hutchings, Emiliana Brocchi, 2011, Validation of a recombinant integrinavb6/monoclonal antibody based antigen ELISA for the diagnosis of foot-and-mouth disease, Journal of Virological Methods, Aug 175 (2), 253-260,
|
News
Links
|